Shareholder Director Nominations

Business Context and Reporting Period

This Form 8-K is a current report filed by Ekso Bionics Holdings, Inc. (not Chronoscale Holdings Corp) on October 22, 2020. The filing announces the scheduling of the Company's 2020 Annual Meeting of Stockholders.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance.

Material Changes

No material financial changes are reported. The primary event is the Board of Directors' decision to hold the 2020 Annual Meeting virtually on December 29, 2020, at 8:30 a.m. Pacific time, due to the ongoing COVID-19 pandemic.

Guidance, Outlook, and Corporate Actions

  • Annual Meeting: Scheduled for December 29, 2020, to be held virtually.
  • Stockholder Proposals: Stockholders wishing to present proposals or nominate directors must submit written notice to the Corporate Secretary by November 2, 2020.
  • Proxy Statement: Further details regarding voting and meeting procedures will be included in the Company Proxy Statement to be filed with the SEC.
  • Compliance: Proposals must adhere to the Company's By-laws and Rule 14a-8 of the Exchange Act to be considered.

Key Facts for Investor Verification

  • Verify the exact date and time of the Annual Meeting (December 29, 2020, 8:30 a.m. PT).
  • Confirm the deadline for submitting stockholder proposals or director nominations (November 2, 2020).
  • Monitor the upcoming Proxy Statement for specific voting instructions and the full agenda.
  • Note that the filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.